Catherine M. Szyman, CVP, Critical Care at Edwards Lifesciences Corp (EW), sold 40,000 shares at $104.31 ($4.2M) on 2022-03-14, disclosed to the SEC on 2022-03-14.
Seasonal sale ($4.2M) by CVP, Critical Care — this insider has traded EW in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.31 | 8,147 | $850K | 20.3% |
| 2 | $104.31 | 8,147 | $850K | 20.3% |
| 3 | $104.88 | 11,853 | $1.2M | 29.7% |
| 4 | $104.88 | 11,853 | $1.2M | 29.7% |
| Total | $104.65 avg | 40,000 | $4.2M | 100% |
| Filing → |
| EW | SELL | 2023-09-08 | $380K | — | Filing → |
| EW | SELL | 2023-08-09 | $393K | — | Filing → |
| EW | SELL | 2023-07-10 | $453K | — | Filing → |